Alzheimer’s Brain Scan Test Gets FDA Approval

The U.S. Food and Drug Administration (FDA) gave the O.K. last Friday to a new radioactive dye that helps doctors scan the brain for Alzheimer’s disease.

The dye, called Amyvid (florbetapir), made by Eli Lilly & Co., binds to the sticky amyloid proteins that build up in the brains of patients with Alzheimer’s. The dye can be detected by using positron emission tomography, or PET scans.

The test could allow doctors to diagnose Alzheimer’s much earlier and more accurately. In patients with symptoms of cognitive decline, the presence of amyloid would support an Alzheimer’s diagnosis. The dye cannot be used alone to diagnose Alzheimer’s, however, especially not in people without symptoms because people with normal brain function may accumulate amyloid plaques as they age, and because the plaques can be associated with neurological conditions other than Alzheimer’s.

via Alzheimer’s Brain Scan Test Gets FDA Approval | Healthland | TIME.com.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s